MSA
GMED icon

Mason Street Advisors’s Globus Medical GMED Stock Holding History

Mason Street Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40,718
Closed -$2.66M – 492
2020
Q4 		$2.66M Buy
40,718
+402
+1% +$23.1K 0.05% 472
2020
Q3 		$2M Sell
40,316
-1,148
-3% -$59.2K 0.04% 518
2020
Q2 		$1.98M Buy
41,464
+523
+1% +$25.2K 0.04% 510
2020
Q1 		$1.74M Hold
40,941
– – 0.04% 495
2019
Q4 		$2.41M Buy
40,941
+746
+2% +$40.5K 0.05% 493
2019
Q3 		$2.06M Sell
40,195
-609
-1% -$29K 0.04% 549
2019
Q2 		$1.73M Buy
40,804
+313
+0.8% +$13.6K 0.04% 634
2019
Q1 		$2M Buy
40,491
+672
+2% +$30.4K 0.04% 582
2018
Q4 		$1.72M Buy
39,819
+2,178
+6% +$109K 0.04% 540
2018
Q3 		$2.14M Buy
37,641
+53
+0.1% +$2.79K 0.04% 525
2018
Q2 		$1.9M Buy
37,588
+1,179
+3% +$61.5K 0.04% 585
2018
Q1 		$1.81M Buy
36,409
+696
+2% +$32.7K 0.04% 581
2017
Q4 		$1.47M Sell
35,713
-124
-0.3% -$4.34K 0.03% 710
2017
Q3 		$1.06M Buy
35,837
+566
+2% +$17.3K 0.03% 822
2017
Q2 		$1.17M Buy
35,271
+1,291
+4% +$40.5K 0.03% 766
2017
Q1 		$1.01M Buy
33,980
+410
+1% +$11.2K 0.03% 806
2016
Q4 		$833K Buy
+33,570
New +$763K 0.02% 854
2015
Q1 		– Sell
-218,430
Closed -$5.19M – 1599
2014
Q4 		$5.19M Hold
218,430
– – 0.04% 539
2014
Q3 		$4.3M Hold
218,430
– – 0.03% 572
2014
Q2 		$5.22M Hold
218,430
– – 0.04% 509
2014
Q1 		$5.81M Hold
218,430
– – 0.05% 456
2013
Q4 		$4.41M Buy
218,430
+44,250
+25% +$821K 0.04% 567
2013
Q3 		$3.04M Buy
+174,180
New +$3.01M 0.03% 519

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Mason Street Advisors's GMED Position: Q1 2021 in Review

Mason Street Advisors sold out of Globus Medical (GMED) in Q1 2021, closing a stake of 40,718 shares — an estimated $2.66M sold.

Mason Street Advisors first reported a position in GMED in Q3 2013 and held it in 23 quarters. The position peaked at $5.81M in Q1 2014. 345 funds tracked by Wall St. Rank hold GMED as of Q1 2021.

  • Mason Street Advisors reported no remaining Globus Medical position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 40,718 Globus Medical shares in Q1 2021, an estimated $2.66M.
  • Mason Street Advisors first reported a position in Globus Medical in Q3 2013 and held it in 23 quarters.
  • Mason Street Advisors's Globus Medical position peaked at $5.81M in Q1 2014.
  • 345 funds tracked by Wall St. Rank held Globus Medical as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.